VARI Jones Archives

GRAND RAPIDS, Mich. (Feb 20, 2018)—Van Andel Research Institute (VARI) Chief Scientific Officer Peter Jones, Ph.D., D.Sc., will be awarded an honorary...

28 Dec 2017

What’s next for VAI in 2018

Tagsbone disease, cancer research, collaboration, Core Technologies and Services, epigenetics, Jewell, Jones, P. Brundin, Parkinson's disease, structural biology, Triezenberg, VAEI, VAIGS, VARI, Williams

With the end of the year approaching, we asked the Institute’s leadership for a sneak peek into what they are most excited...

21 Dec 2017

10 highlights: A look back at 2017

Tagsaward, Baylin, cancer, collaboration, cryo-EM, GCPD, Jones, New Hire, Parkinson's disease, VAEI, VAIGS, VARI, VARI-SU2C

With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s...

12 Oct 2017

A Catalyst for combating cancer

TagsBaylin, cancer research, Jones, SU2C, VARI

Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr....

12 Oct 2017

Stand Up To Cancer awards $5.5 million to VARI for cancer clinical trials to enhance immunotherapy

TagsBaylin, bladder cancer, cancer research, Featured Stories, Jones, lung cancer, SU2C

15 Jun 2017

VARI’s Chief Scientific Officer won an Outstanding Investigator Award. Here’s what that means.

Tagsaward, epigenetics, Jones, VARI

VARI’s Chief Scientific Officer Peter Jones, Ph.D., D.Sc., has received a highly competitive 7-year, $7.8 million Outstanding Investigator Award grant from the...

13 Jun 2017

VARI-SU2C Epigenetics Dream Team launches new clinical trial to combat blood cancers

TagsJones, SU2C, VARI, VARI-SU2C

International collaboration pairs immunotherapy with an epigenetic drug to stop progression of chronic myelomonocytic leukemia and myelodysplastic syndrome into acute myeloid leukemia...